EUVIMEDEUVIMED entdecken
Crossref

Docetaxel, doxorubicin and cyclophospharmide as neoadjuvant chemotherapy with primary prophylactic stem cell growth factor support in locally advanced breast cancer (T3 – T4 , No – 3, Mo)

Ehab Elnakory, Samiah Abdulrazek, Ashraf Fawzy

Research in Oncology · 2006

DOI: 10.21608/resoncol.2006.354 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research in Oncology, 2006. Verfasst von Ehab Elnakory und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Elnakory, E., Abdulrazek, S., & Fawzy, A. (2006). Docetaxel, doxorubicin and cyclophospharmide as neoadjuvant chemotherapy with primary prophylactic stem cell growth factor support in locally advanced breast cancer (T3 – T4 , No – 3, Mo). Research in Oncology. https://doi.org/10.21608/resoncol.2006.354

Vancouver

Elnakory E, Abdulrazek S, Fawzy A. Docetaxel, doxorubicin and cyclophospharmide as neoadjuvant chemotherapy with primary prophylactic stem cell growth factor support in locally advanced breast cancer (T3 – T4 , No – 3, Mo). Research in Oncology. 2006. doi:10.21608/resoncol.2006.354

BibTeX
@article{Elnakory2006,
  author = {Elnakory, Ehab and Abdulrazek, Samiah and Fawzy, Ashraf},
  title = {Docetaxel, doxorubicin and cyclophospharmide as neoadjuvant chemotherapy with primary prophylactic stem cell growth factor support in locally advanced breast cancer (T3 – T4 , No – 3, Mo)},
  journal = {Research in Oncology},
  year = {2006},
  doi = {10.21608/resoncol.2006.354}
}
Kostenlos starten →